Skip to content Skip to footer
Subscribe Now
Laura Yecies, CEO at Bone Health Technologies Shares Insights on Osteoporosis Prevention Study for Postmenopausal Women With Osteopenia
VIEWPOINTS

Laura Yecies, CEO at Bone Health Technologies Shares Insights on Osteoporosis Prevention Study for Postmenopausal Women With Osteopenia

Shots: Laura spoke about the non-drug intervention study to treat osteopenia in postmenopausal women She also talked about the company’s OsteoBoost technology which is a convenient treatment to improve bone density The interview provides an understanding of the company’s vision to develop new treatment options for osteoporosis and osteopenia Smriti: Brief us about the background behind…
August 17, 2022

Read more

Leonard Glass, Vice President, Global Medical Affairs at Eli Lilly & Co. Shares Insights from Lilly’s Vision on New Stage of Metabolic Science
VIEWPOINTS

Leonard Glass, Vice President, Global Medical Affairs at Eli Lilly & Co. Shares Insights from Lilly’s Vision on New Stage of Metabolic Science

Shots: Leonard spoke about how Lilly is advancing in the field of metabolic disease research (esp. diabetes) He also talked about its lead candidate in type 2 diabetes and also discussed its clinical results in detail The interview summarizes Lilly’s objective to advance new discoveries and redefine diabetes care Smriti: Tell us how Lilly is leading…
August 16, 2022

Read more

PharmaShots Interview Laurent Levy, CEO of Nanobiotix Shares Insights and Clinical Updates on its Nanoparticle Therapy
VIEWPOINTS

PharmaShots Interview: Laurent Levy, CEO of Nanobiotix Shares Insights and Clinical Updates on its Nanoparticle Therapy

Shots:  Laurent spoke about the study design of its nanoparticle therapy to enhance the cancer-killing effect of radiation, which was presented at ASCO 2022 Laurent also highlighted how this nanoparticle therapy can be a potential radio enhancer in various tumor types and across lines of therapy The interview summarizes Nanobiotix’s vision to advance nanoparticles across…
August 10, 2022

Read more

PharmaShots Interview Dr. R. Preston Mason, Consultant at Amarin, Corp. Shares Insights from its in vitro Study Results
VIEWPOINTS

PharmaShots Interview: Dr. R. Preston Mason, Consultant at Amarin, Corp. Shares Insights from its in vitro Study Results

Shots: Dr. Mason spoke about the key findings from their in vitro study demonstrating EPA + statins effects in reduced lipid oxidation, which were presented at the ACC 2022 He also spoke about the study design of the REDUCE-IT trial and its importance in the approval of its candidate in metabolic and cardiovascular diseases The interview summarizes…
August 3, 2022

Read more

PharmaShots Interview Purnanand Sarma, CEO of Immunome, Shares Insights on R&D Update IL-38 Targeting Antibody Treatment for Cancer
VIEWPOINTS

PharmaShots Interview: Purnanand Sarma, CEO of Immunome, Shares Insights on R&D Update IL-38 Targeting Antibody Treatment for Cancer

Shots:  Purnanand spoke about the preclinical results of lead candidate in oncology and how its identifies IL-38 as a target to treat cancer Purnanand also talked about Immunome’s collaboration with Fox Chase Cancer Center for the further development of its prime product The interview gives a understanding of Immunome’s goal of developing therapeutics to treat…
August 2, 2022

Read more

Exclusive Interview_Philip M. Brown_Dr. Anna Tallman
EXCLUSIVE

Philip Brown & Anna Tallman of Dermavant Shares Insights on the Approval of its Topical Treatment for Plaque Psoriasis

Shots: Philip spoke about plaque psoriasis, symptoms, prognosis, and treatment options available. He also discussed different ongoing patient support programs by Dermavant Anna talked about the approval of Dermavant’s lead topical treatment in plaque psoriasis, its clinical studies & results The interview summarizes Dermavant’s aim to develop innovative therapeutics in immuno-dermatology to address the high…
August 1, 2022

Read more

PharmaShots Interview Abdul Mullick, CEO at Kyowa Kirin Shares Insights on the Launch of a Virtual Exhibition to Highlight Issues of Rare Disease, X-linked Hypophosphataemia
VIEWPOINTS

PharmaShots Interview: Abdul Mullick, CEO at Kyowa Kirin Shares Insights on the Launch of a Virtual Exhibition to Highlight Issues of Rare Disease, X-linked Hypophosphataemia

Shots: Abdul spoke about the launch of a digital exhibition ‘Shine a light’ to raise awareness about rare diseases Abdul also emphasized the significance of this awareness campaign for the patients who were unaware of X-linked Hypophosphataemia(XLH) The interview provides a profound understanding of Kyowa Kirin's initiatives to help patients suffering from XLH Smriti: Can we…
July 27, 2022

Read more

PharmaShots Interview Daphne Chan, Head of Dermatology Medical Affairs at Janssen Shares Insights on Clinical Study in Dermatology
VIEWPOINTS

PharmaShots Interview: Daphne Chan, Head of Dermatology Medical Affairs at Janssen Shares Insights on Clinical Study in Dermatology

Shots: Daphne talked about the P-III study evaluating the safety and efficacy of Tremfya in people of color living with moderate to severe plaque psoriasis Daphne also spoke about how this clinical study will contribute to fill the gaps in care of people who are devoid of treatment due to racial and ethnic variations The…
July 26, 2022

Read more

Exclusive Interview_Shmulik Shapiro
EXCLUSIVE

Shmulik Shapiro, EVP of Business Development & Strategy at RSIP Vision Shares Insight on New AI Tool for Prostate MRI Analysis that Supports PI-RADS Scoring

Shots: Shmulik spoke about the key features and development of the new AI tool for Prostate MRI Analysis Shmulik emphasized the significance of this new tool in PI-RADS score and how this can be helpful in diagnosing prostate lesions in MRI The interview provides a deeper understanding of medical imaging technologies that are emerging through…
July 25, 2022

Read more

PharmaShots Celebrates Blooming 4 Years of Accomplishments
Announcements

PharmaShots Celebrates Blooming 4 Years of Accomplishments

PharmaShots Team is pleased to announce the completion of our 4 years, PharmaShots commenced its journey on the path of delivering real-time concise news focused on the Global Healthcare and Life Sciences Industry With a flourishing completion of 4 years, PharmaShots is delighted to announce an upgraded App, Exclusive & Spotlight Interviews, and ThoughtSpot services, along with a launch…
July 25, 2022

Read more

Load more